Research study Program year 2019 Source: CMS Open Payments

OPTIC- Phase 2 CML Efficacy-Safety

Research payments

$223,461

96 payments

Through program year 2019, $223,461 in research payments was reported against OPTIC- Phase 2 CML Efficacy-Safety, across 96 payments, paid by Takeda Pharmaceuticals U.S.A., Inc..

Paid by: Takeda Pharmaceuticals U.S.A., Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

1 row

Year	Kind	Amount	Payments
2019	Research	$223,461	96

Breakdown

Who paid Research payments · program year 2019

Takeda Pharmaceuticals U.S.A., Inc. $223,461 96 payments

Who received the money Research payments · program year 2019

The Univ Of Texas MD Anderson Cancer Ctr Organisation paid for research $61,808 15 payments
Regents Of The University Of Minnesota Organisation paid for research $23,375 7 payments
Karmanos Cancer Hospital Teaching hospital · MI $22,873 13 payments
Unehealth Organisation paid for research $22,355 6 payments
Hackensack University Medical Center Teaching hospital · NJ $17,619 6 payments
Memorial Sloan Kettering Cancer Center Organisation paid for research $17,438 2 payments
Applied Clinical Intelligence LLC Organisation paid for research $15,896 16 payments
The Trustees Of The University Of Organisation paid for research $13,505 6 payments
Emory University Hospital Teaching hospital · GA $7,757 4 payments
U Of U Hospitals & Clinics Teaching hospital · UT $6,365 4 payments

Usually the institution or organisation running the study, not a person.

What the money was spent on Research payments · program year 2019

Other $221,100 89 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.